Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment - ScienceDirect

Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment - ScienceDirect: Androgen receptor (AR) antagonists, such as enzalutamide, have had a major impact on the treatment of metastatic castration-resistant prostate cancer …

Comments

Post a Comment

Popular posts from this blog

Researchers develop low-cost device that detects cancer in an hour | ScienceDaily

Image
Summary Sanjay S. Timilsina , currently Lead Scientist, StataDx, a spinoff from Wyss Institute, former Postdoctoral Fellow at Harvard Medical School and the Wyss Institute at Harvard University, PhD from UTEP Department of Chemistry & Biochemistry, and XiuJun Li full Professor in the Department of Chemistry and Biochemistry and of Forensic Science, & Environmental Science and Engineering, at the University of Texas at El Paso (UTEP) have developed a new portable device for cancer detection that offers several advantages over traditional methods: Key Features: - Low cost (a few dollars per device, <8 cents per assay) - Provides results in about 1 hour (vs. 12-16 hours for traditional methods) - Approximately 10 times more sensitive than traditional methods - Portable and doesn't require specialized instruments - Can detect both CEA colorectal and PSA prostate cancer biomarkers - Uses a "paper-in-polymer-pond" structure to analyze blood samples How it works: - U
Read more

Cancer patients and doctors team up to change how cancer drugs are tested | Fox News

Cancer patients and doctors team up to change how cancer drugs are tested | Fox News foxnews.com Associated Press For cancer patients, the harsh side effects of powerful drugs have long been the trade-off for living longer. Now, patients and doctors are questioning whether all that suffering is necessary. They’ve ignited a movement to radically change how new cancer drugs are tested, with the U.S. Food and Drug Administration urging drugmakers to do a better job at finding the lowest effective dose, even if it takes more time. Advances in treatment mean millions of people are surviving for years with incurable cancers. Jill Feldman, 54, of Deerfield, Illinois, has lived 15 years with lung cancer , thanks to that progress. Her parents both died of lung cancer months after their diagnoses. But her cancer drug causes joint pain, fatigue and mouth sores that m
Read more

Member Roundtable Discussion - YouTube

Image
Member Roundtable Discussion - YouTube Round Table Discussion July 20, 2024 Informed Prostate Cancer Support Group Meeting Summary Overall Summary: This July 20 th meeting of a prostate cancer support group was the first in person meeting of the IPCSG in the newly refurbished Sanford Burnham Prebys Medical Exploration Auditorium. The session included presentations from three speakers who shared their personal experiences with prostate cancer, treatment approaches, and insights into managing the disease. The meeting also addressed the importance of self-advocacy, staying informed, and maintaining a positive outlook while dealing with prostate cancer. Contributions: 1. Bill Manning: Bill shared his journey with active surveillance over 15 years. He emphasized the importance of regular testing and monitoring, including PSA tests, MRIs, and biopsies. Bill discussed how he avoided unnecessary treatment by carefully tracking his condition and making informed decisions. He
Read more